Tabata, Yasuhiko
Kyoto University,
Japan
2025 Rank: 3901
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biomedical Engineering
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 18 out of 70250 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3901 | 3032 |
| Total Cites | 39751 | 48129 |
| H-index | 97 | 107 |
| Hm-index | 49 | 55 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 980 | 1129 |
| Number of Single+First Authored Papers | 91 | 91 |
| Total Cites to Single+First Authored Papers | 4800 | 6010 |
| Number of Single+First+Last Authored Papers | 430 | 430 |
| Total Cites to Single+First+Last Authored Papers | 14611 | 18290 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 29767 | 32023 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.50 |
| Self-Citation Percentage |
17.41%
|
|
Tabata, Yasuhiko
Kyoto University,
Japan
2024 Rank: 3749
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biomedical Engineering
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 18 out of 66541 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3749 | 2896 |
| Total Cites | 37448 | 45757 |
| H-index | 94 | 105 |
| Hm-index | 49 | 54 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 938 | 1087 |
| Number of Single+First Authored Papers | 91 | 91 |
| Total Cites to Single+First Authored Papers | 4657 | 5869 |
| Number of Single+First+Last Authored Papers | 429 | 429 |
| Total Cites to Single+First+Last Authored Papers | 13907 | 17580 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 27877 | 30102 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.52 |
| Self-Citation Percentage |
18.16%
|
|
Tabata, Yasuhiko
Institute for Frontier Life and Medical Sciences,
Japan
2023 Rank: 3750
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biomedical Engineering
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 18 out of 62597 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3750 | 2825 |
| Total Cites | 35097 | 43231 |
| H-index | 89 | 101 |
| Hm-index | 47 | 53 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 894 | 1043 |
| Number of Single+First Authored Papers | 91 | 91 |
| Total Cites to Single+First Authored Papers | 4492 | 5698 |
| Number of Single+First+Last Authored Papers | 429 | 429 |
| Total Cites to Single+First+Last Authored Papers | 13160 | 16791 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 25996 | 28149 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.54 |
| Self-Citation Percentage |
18.82%
|
|
Tabata, Yasuhiko
Institute for Frontier Life and Medical Sciences,
Japan
2022 Rank: 3730
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biomedical Engineering
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 17 out of 59238 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3730 | 2760 |
| Total Cites | 32339 | 40226 |
| H-index | 86 | 97 |
| Hm-index | 46 | 52 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 824 | 973 |
| Number of Single+First Authored Papers | 91 | 91 |
| Total Cites to Single+First Authored Papers | 4284 | 5488 |
| Number of Single+First+Last Authored Papers | 429 | 429 |
| Total Cites to Single+First+Last Authored Papers | 12199 | 15749 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 23866 | 25940 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.55 |
| Self-Citation Percentage |
19.61%
|
|
Tabata, Yasuhiko
Institute for Frontier Life and Medical Sciences,
Japan
2021 Rank: 3634
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biomedical Engineering
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 21 out of 64425 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3634 | 2735 |
| Total Cites | 31002 | 38677 |
| H-index | 85 | 95 |
| Hm-index | 45 | 50 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 797 | 943 |
| Number of Single+First Authored Papers | 90 | 90 |
| Total Cites to Single+First Authored Papers | 4158 | 5349 |
| Number of Single+First+Last Authored Papers | 419 | 419 |
| Total Cites to Single+First+Last Authored Papers | 11744 | 15177 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 22872 | 24892 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.55 |
| Self-Citation Percentage |
19.84%
|
|
Tabata, Yasuhiko
Institute for Frontier Life and Medical Sciences,
Japan
2020 Rank: 3707
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biomedical Engineering
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 23 out of 50331 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3707 | 2765 |
| Total Cites | 28004 | 35259 |
| H-index | 80 | 89 |
| Hm-index | 42 | 48 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 740 | 883 |
| Number of Single+First Authored Papers | 91 | 91 |
| Total Cites to Single+First Authored Papers | 3954 | 5130 |
| Number of Single+First+Last Authored Papers | 405 | 405 |
| Total Cites to Single+First+Last Authored Papers | 10766 | 14041 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 20537 | 22430 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.57 |
| Self-Citation Percentage |
20.58%
|
|